Skip to main content
. 2018 Jul 5;33(10):1701–1712. doi: 10.1007/s00467-018-3958-7

Table 2.

Associations between gene and renal phenotype

Gene Patients Families Median age (range)a (years) Median age symptom onset (range)a(years) Median age ESRD (range)a(years) Median time to ESRD (range)a,b(years) Polyuria Polydipsia Enuresis Renal ultrasound findings
Cysts Abnormal corticomedullary differentiation Increased echogenicity
NPHP1 n = 16 n = 14 21 (9–62) 9 (6–26) 14 (7–28) 1 (0–8) 90% (9/10) 80% (8/10) 38% (3/8) 33% (4/12) 38% (3/8) 70% (7/10)
NPHP4 n = 3 n = 3 19 (11–41) 16 (8–24) 8 0 33% (1/3) 67% (2/3) 0% (0/3) 50% (1/2) 50% (1/2) 100% (2/2)
WDR35 n = 3 n = 2 17 (12–33) 9 12 3 67% (2/3) 50% (1/2) 0% (0/2) 67% (2/3) 33% (1/3) 100% (2/2)
BBS1 n = 2 n = 1 18 (16–20) NA NA 0% (0/1) 0% (0/1) 0% (0/1) 50% (1/2) 0% (0/2) 0% (0/2)
AHI1 n = 1 n = 1 25 14 NA 0% (0/1) 0% (0/1) 0% (0/1) 0% (0/1) 0% (0/1) 0% (0/1)
BBS10 n = 1 n = 1 13 NA NA 100% (1/1) 100% (1/1) 0% (0/1) 100% (1/1) 100% (1/1) 100% (1/1)
IQCB1 n = 1 n = 1 29 NA 10 NA NA NA NA NA NA NA
OFD1 n = 1 n = 1 12 5 5 0 NA NA NA 0% (0/1) 0% (0/1) 100% (1/1)
Unknown n = 12 n = 12 21 (15–54) 13 (5–33) 14 (8–47) 11 (8–14) 33% (2/6) 86% (6/7) 33% (1/3) 50% (4/8) 17% (1/6) 57% (4/7)
Total n = 40 n = 36 19 (9–62) 9 (5–33) 13 (5–47) 1 (0–14) 60% (15/25) 72% (18/25) 21% (4/19) 43% (13/30) 32% (7/22) 65% (17/26)

ESRD end-stage renal disease; absent, no ESRD; NA not available

aWhen range is not reported, the value is based on one patient

bPatient age at CKD stage 5 was used as the age at ESRD. If this was not available, the youngest reported age at the start of dialysis/transplantation was used. Median time to ESRD could be an underestimate because patients who did not develop ESRD were not included in this calculation